Discovery of a fluorescent cyclin-dependant kinase inhibitor with potent antiproliferative activity in human breast cancer cells

被引：0
|
作者：
Yenugonda, Venkata Mahidhar
Deb, Tushar B.
Grindrod, Scott C.
Dakshanamurthy, Sivanesan
Yang, Yonghong
Paige, Mikell
Brown, Milton L.
机构：
[1] Georgetown Univ, Med Ctr, Drug Discovery Program, Washington, DC 20007 USA
[2] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
509-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Recent progress in the discovery and development of cyclin-dependant kinase inhibitors
    Fischer, PM
    Gianella-Borradori, A
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (04) : 457 - 477
  • [2] Reversal of collasping glomerulopathy in mice with the cyclin-dependant kinase inhibitor CYC202.
    Nelson, PJ
    Gherardi, D
    D'Agati, VD
    Chu, THT
    Barnett, A
    Gianella-Borradori, A
    Gelman, IH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 26A - 26A
  • [3] Pneumocystis carinii modulates cyclin-dependant kinase activity in a lung epithelial cell line
    Anders, RA
    Gustafson, M
    Edens, M
    Limper, AH
    Leof, EB
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1996, 43 (05) : S13 - S13
  • [4] Discovery of a potent and selective ATAD2 inhibitor with antiproliferative activity in breast cancer models
    Kulkarni, Meghana M.
    Winter, Jon
    Whalley, David
    Dale, Ian
    Denz, Christopher
    Guan, Nin
    Bhavsar, Deepa
    Zhang, Andrew
    Rasmusson, Timothy
    Fretland, Adrian
    Guichard, Sylvie M.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [5] Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
    Winter-Holt, Jon J.
    Bardelle, Catherine
    Chiarparin, Elisabetta
    Dale, Ian L.
    Davey, Paul R. J.
    Davies, Nichola L.
    Denz, Christopher
    Fillery, Shaun M.
    Guerot, Carine M.
    Han, Fujin
    Hughes, Samantha J.
    Kulkarni, Meghana
    Liu, Zhaoqun
    Milbradt, Alexander
    Moss, Thomas A.
    Niu, Huijun
    Patel, Joe
    Rabow, Alfred A.
    Schimpl, Marianne
    Shi, Junjie
    Sun, Dongqing
    Yang, Dejian
    Guichard, Sylvie
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 3306 - 3331
  • [6] Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells
    Yenugonda, Venkata Mahidhar
    Deb, Tushar B.
    Grindrod, Scott C.
    Dakshanamurthy, Sivanesan
    Yang, Yonghong
    Paige, Mikell
    Brown, Milton L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (08) : 2714 - 2725
  • [7] Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6
    Toogood, PL
    Harvey, PJ
    Repine, JT
    Sheehan, DJ
    VanderWel, SN
    Zhou, HR
    Keller, PR
    McNamara, DJ
    Sherry, D
    Zhu, T
    Brodfuehrer, J
    Choi, C
    Barvian, MR
    Fry, DW
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) : 2388 - 2406
  • [8] A novel histone deacetylase inhibitor with potent antiproliferative activity in ovarian cancer cells.
    Mand, Michael
    Edwards, Ceazon
    Tumati, Vasu
    Kulp, Samuel K.
    Chen, Ching-Shih
    Nephew, Kenneth P.
    Balch, Curtis
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer
    Annette Schmider-Ross
    Olaf Pirsig
    Elisabeth Gottschalk
    Carsten Denkert
    Werner Lichtenegger
    Angela Reles
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 163 - 170
  • [10] Lemonquats volatile demonstrate antiproliferative activity against androgen dependant human prostate cancer (LNCaP) cells
    Jayaprakasha, G. K.
    Murthy, K. N. C.
    Uckoo, Ram M.
    Patil, Bhimanagouda S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
12345